KALA BIO, Inc.
KALA
$5.10
$0.050.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.95M | -8.18M | -8.95M | -9.58M | -11.81M |
| Total Depreciation and Amortization | 68.00K | 69.00K | 63.00K | 61.00K | 66.00K |
| Total Amortization of Deferred Charges | 186.00K | 299.00K | 322.00K | 315.00K | 312.00K |
| Total Other Non-Cash Items | 2.42M | 2.18M | 2.55M | 2.04M | 2.63M |
| Change in Net Operating Assets | -2.55M | 1.03M | 1.29M | -2.05M | -2.05M |
| Cash from Operations | -8.82M | -4.60M | -4.73M | -9.22M | -10.84M |
| Capital Expenditure | -- | -69.00K | -90.00K | -36.00K | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -69.00K | -90.00K | -36.00K | -13.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -28.00K | -5.03M | -18.00K | -- | -- |
| Issuance of Common Stock | 13.00K | 11.67M | -- | 14.97M | 21.00K |
| Repurchase of Common Stock | -- | -- | -162.00K | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 0.00 | 8.54M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -120.00K | 0.00 | 0.00 | 0.00 | -119.00K |
| Cash from Financing | -135.00K | 6.65M | -180.00K | 14.97M | 8.44M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.96M | 1.98M | -5.00M | 5.72M | -2.42M |